greeksoup/ stock research

Option Care Health (OPCH) Q1 FY2024 earnings: revenue $1.1 billion, up 12.8% on the year

Option Care Health, Inc. (OPCH) reported revenue of $1.1 billion for Q1 FY2024, the quarter ended 31 March 2024, up 12.8% on the same quarter a year earlier. Net income was $45 million, up 14.2% on the year, and diluted earnings per share $0.26. The figures are the company's own, from the 10-Q it filed with the SEC on 29 April 2025.

Revenue$1.1 billionup 12.8%
Net income$45 millionup 14.2%
Diluted EPS$0.26
QuarterQ1 FY2024ended 31 March 2024

The quarter, against the one before and a year earlier

LineQ1 FY2024Q4 FY2023A year earlierChange on the year
Revenue1,1461,124n/an/a
Cost of revenue908877n/an/a
Gross profit238247n/an/a
Gross margin20.8%22.0%n/a
Selling, general and administrative155148n/an/a
Operating income69.084.6n/an/a
Operating margin6.0%7.5%n/a
Interest expense13.212.4n/an/a
Pre-tax income57.078.9n/an/a
Income tax12.221.7n/an/a
Effective tax rate21.4%27.6%n/a
Net income44.857.2n/an/a
Net margin3.9%5.1%n/a
Diluted EPS$0.26$0.32n/an/a
$ million except per share.
Read moreFourth quarters are the year less the first three quarters. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow and capital returned

LineQ1 FY2024Q4 FY2023A year earlierChange on the year
Operating cash flow-68.851.0n/an/a
Capital expenditure5.819.9n/an/a
Free cash flow-74.631.1n/an/a
Free cash flow margin-6.5%2.8%n/a
Cash from investing-5.8-15.8n/an/a
Cash from financing-49.7-77.8n/an/a
Depreciation and amortisation14.714.8n/an/a
Share-based compensation9.67.6n/an/a
Buybacks40.075.2n/an/a
Diluted shares, weighted176m178mn/an/a
Shares outstanding at period end174m175mn/an/a

Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.

Balance sheet at quarter end

LineQ1 FY2024Q4 FY2023A year earlierChange on the year
Shareholders' equity1,4291,422n/an/a
Debt1,0621,063n/an/a
Operating lease liabilities89.285.5n/an/a
Other liabilities669647n/an/a
Total liabilities and equity3,2503,217n/an/a
Fixed assets121121n/an/a
Goodwill1,5401,540n/an/a
Intangible assets327335n/an/a
Cash and equivalents220344n/an/a
Receivables574378n/an/a
Inventory242274n/an/a
Other assets226225n/an/a
Total assets3,2503,217n/an/a

Quarterly results, the last 12 quarters

Q3 FY2023Q4 FY2023 *Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024 *Q1 FY2025Q2 FY2025 †Q3 FY2025Q4 FY2025 *Q1 FY2026Q2 FY2026
Revenue1,0931,1241,1461,2271,2791,3461,3331,4161,4351,4651,3511,442
Cost of revenue8398779089781,0221,0781,0701,1471,1621,1831,0891,175
Gross profit254247238249257268263269273283262267
Gross margin23%22%21%20%20%20%20%19%19%19%19%19%
SG&A158148155154157165168170172172175165
Operating income81.084.669.080.785.187.079.282.784.591.572.585.1
Operating margin7%8%6%7%7%6%6%6%6%6%5%6%
Interest expense11.812.413.212.612.310.913.214.414.112.713.314.0
Pre-tax income70.178.957.072.073.681.063.668.969.081.561.074.0
Tax rate20%28%21%26%27%26%26%27%25%28%26%27%
Net income56.357.244.853.053.960.146.750.551.858.545.353.9
Net margin5%5%4%4%4%4%4%4%4%4%3%4%
Diluted EPS$0.31$0.32$0.26$0.30$0.31$0.36$0.28$0.31$0.32$0.37$0.29$0.35
Operating cash flow61.051.0-68.819616036.1-7.290.313935.9-12.1184
Capital expenditure8.419.95.89.89.710.39.49.19.213.69.011.1
Free cash flow52.631.1-74.618615125.8-16.681.213022.2-21.2173
Buybacks10075.240.078.142.092.6n/an/a62.5n/an/an/a
Shares outstanding177m175m174m171m170m166m164m162m160m157m157m150m
Filing10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q
Each quarter as filed, linked to its filing.
Read more* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS and diluted share count are from the company's results press release for that quarter, used where the release gives the same revenue and net income as the table. A quarter marked † is shown as the company last restated it in a later filing, so it compares with the quarters around it on one basis; rest on a figure for the one first filed. EPS is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

Source

10-Q for the period ended 31 March 2024, filed 29 April 2025, accession 0001014739-25-000022: the filing on EDGAR. All of Option Care Health, Inc.'s filings: EDGAR company page.

The same record on your computer

GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.

Install